Latest Regulatory Progress News

Bathurst Resources’ subsidiary Telkwa Mining has released an updated feasibility study for its Tenas Steelmaking Coal Project, confirming reserve validity and boosting project valuation despite significant cost inflation.

Locksley Resources has gained critical regulatory approval and secured contractors to advance its Mojave Project, accelerating exploration of antimony and rare earth elements in California.

Echo IQ reports a remarkable 153% increase in echocardiogram processing through its EchoSolv AS platform in the US, with a Mayo Clinic validation study nearing completion ahead of a critical FDA submission. The company is also advancing European market entry and strengthening its advisory team to accelerate global growth.

Global Uranium and Enrichment Limited reports promising drilling outcomes and regulatory progress at its Pine Ridge Uranium Project in Wyoming, reinforcing its potential amid a strengthening uranium market.

Carnavale Resources’ updated Scoping Study for the Kookynie Gold Project reveals a doubling in project value and robust economics, supporting a five-year mine life with 93,000 ounces of gold production.

Audalia Resources has completed a $500,000 placement to a sophisticated investor, issuing 20 million shares to fund critical development stages at its Medcalf Project. The capital injection aims to advance mining design, permits, and approvals while bolstering working capital.

OzAurum Resources has launched a targeted drilling campaign at its Mulgabbie North Gold Project, aiming to expand high-grade zones and advance feasibility studies amid record gold prices.

Anteris Technologies has gained shareholder approval for an ASX waiver allowing flexible capital raising and updated its PARADIGM trial timeline, now set to begin patient enrolment in Q4 2025 after addressing FDA requests.

CurveBeam AI has secured A$6.5 million through an institutional placement and completed a €10 million vendor financing facility to accelerate sales of its HiRise™ CT scanner. The company is also progressing a strategic partnership in China and advancing surgical robot validation.

Paterson Resources has announced a $2 million capital raising via a placement and a non-renounceable entitlement offer, aimed at advancing its Grace Project in Western Australia. The offer includes new shares priced at $0.018 each and free attaching options, with proceeds earmarked for drilling, studies, and working capital.

Race Oncology has secured Investigational New Drug approval from South Korea’s regulatory authority, enabling Phase 1 clinical trials of RC220 in combination with doxorubicin for solid tumour patients across four Korean sites.

Deterra Royalties has agreed to sell its non-core gold offtakes and royalties to Vox Royalty Corp for US$60 million, marking the completion of its divestment of Trident-acquired assets and reinforcing its strategic focus on base and battery metals.